Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Update

Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 256,400 shares, an increase of 140.3% from the December 31st total of 106,700 shares. Based on an average daily volume of 164,600 shares, the short-interest ratio is presently 1.6 days. Approximately 4.1% of the shares of the stock are short sold.

Bullfrog AI Stock Performance

Bullfrog AI stock traded up $0.38 during trading hours on Thursday, hitting $2.65. 938,205 shares of the stock were exchanged, compared to its average volume of 465,087. Bullfrog AI has a 12 month low of $1.43 and a 12 month high of $5.89. The business’s 50-day moving average is $2.23 and its two-hundred day moving average is $2.45. The stock has a market capitalization of $23.08 million, a P/E ratio of -3.12 and a beta of 0.13.

Bullfrog AI (NASDAQ:BFRG) last released its quarterly earnings results on Friday, November 8th. The company reported ($0.22) earnings per share (EPS) for the quarter.

Hedge Funds Weigh In On Bullfrog AI

A hedge fund recently bought a new stake in Bullfrog AI stock. Renaissance Technologies LLC bought a new position in Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 19,800 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned 0.25% of Bullfrog AI as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 0.96% of the company’s stock.

About Bullfrog AI

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.